Purchase Order 75N91020P00800

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $24,095.00 on August 6, 2021, for EVOS M5000 DSS equipment with a one-year reorder exchange provision. The order was issued to administratively de-obligate unexpiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) prior to the September 30, 2021 close of the fiscal year period of availability. Performance occurs at Grand Island, New York. The purchase order carries firm...

<p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>

<p>The National Cancer Institute awarded a purchase order to Thermo Electron North America LLC valued at $24,954.71 on February 5, 2020, with an ultimate completion date of August 10, 2020. Performance is at Bethesda, Maryland. The order is for service agreement work under firm fixed-price terms with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Bioscience International Inc. for $24,080 in scientific equipment on April 23, 2020, with completion by May 31, 2020. Work is performed in North Bethesda, Maryland. The order procures environmental sampling products, including bioaerosol samplers and related air monitoring equipment, to support air quality monitoring and testing capabilities.</p>

<p>The National Cancer Institute awarded a purchase order to Menarini Silicon Biosystems, Inc. for $20,083.33 on September 28, 2016. The order funds an application scientist position supporting a DEP array instrument. Place of performance is Bethesda, Maryland. The order represents a de-obligation of expiring FY2016 funds with an ultimate completion date of March 30, 2021.</p>

<p>The National Cancer Institute issued a purchase order to Fisher Scientific Company L.L.C. for $24,999.00 in scientific equipment on September 16, 2020, with completion on October 31, 2020. Performance occurs in Hanover Park, Illinois. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to EMD Millipore Corp for $24,879.65 in laboratory equipment and supplies on September 15, 2020, with completion by December 1, 2020. Performance takes place in Burlington, Massachusetts. The order carries no small business set-aside. Pricing is firm fixed price.</p>

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. for laboratory equipment. The firm fixed price contract has a period of performance from September 6, 2023 through October 28, 2023 and will be performed in Wellesley Hills, Massachusetts. No additional details were provided regarding the specific laboratory equipment being procured. The National Cancer Institute conducts and supports...

The National Cancer Institute awarded a $11,689.91 firm fixed-price Blanket Purchase Agreement (BPA) call to Eppendorf North America, Inc. for laboratory supplies. The contract was awarded on December 29, 2022, with an ultimate completion date of January 27, 2023, and will be performed in Hauppauge, New York. This contract award was made without a set-aside designation, reflecting Eppendorf North America's status as a large, foreign-owned entity. The BPA call is part of Eppendorf's larger $10...